Eukaryotic cell cycle progression is governed by multiple cyclin and c
yclin-dependent kinases interactions that are in turn regulated by mul
tiple factors. Recently, inhibitors of cyclin/cyclin-dependent kinases
activities have been characterized and their genes have been cloned.
Alterations of some these genes may play a major in tumor initiation o
r progression.